What is a Patient Information Leaflet and why is it useful?

The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using a medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.

Below is a text only representation of the Patient Information Leaflet. The original leaflet can be viewed using the link above.

The text only version may be available in large print, Braille or audio CD. For further information call emc accessibility on 0800 198 5000. The product code(s) for this leaflet is: PL 12762/0056 .


Codipar 15mg/500mg Effervescent Tablets

PACKAGE LEAFLET: INFORMATION FOR THE USER

Codipar® 15mg/500mg

Effervescent Tablets

Codeine Phosphate Hemihydrate/Paracetamol

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this leaflet. You may need to read it again.
  • If you have any further questions, ask your doctor, pharmacist or nurse.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
  • If you get any side effects, talk to your doctor pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

The name of your medicine is Codipar® 15mg/500mg Effervescent Tablets. It will be referred to as Codipar Effervescent Tablets for ease hereafter.

What is in this leaflet

1.What Codipar Effervescent Tablets are and what they are used for
2. What you need to know before you take Codipar Effervescent Tablets
3. How to take Codipar Effervescent Tablets
4. Possible side effects
5. How to store Codipar Effervescent Tablets
6. Contents of the pack and other information

1. WHAT CODIPAR EFFERVESCENT TABLETS ARE AND WHAT THEY ARE USED FOR

Codipar Effervescent Tablets contain paracetamol and codeine. Paracetamol is an analgesic (relieves pain) and an antipyretic (lowers raised temperatures). This product contains codeine. Codeine belongs to a group of medicines called opioid analgesics which act to relieve pain.

Codipar Effervescent Tablets are used for the relief of mild to severe short term pain. Codipar can be used in children over 12 years of age for the short-term relief of moderate pain that is not relieved by other painkillers such as paracetamol or ibuprofen alone.

2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE CODIPAR EFFERVESCENT TABLETS

Do not take with any other paracetamol-containing products. Do not take for longer than directed by your prescriber. Do not use Codipar for pain relief in children and adolescents (0-18 years of age) after removal of their tonsils or adenoids as Codeine in Codipar may cause obstructive sleep apnoea syndrome (sleep disruption due to respiratory pauses). Taking codeine regularly for a long time can lead to addiction, which might cause you to feel restless and irritable when you stop the tablets. Taking a painkiller for headaches too often or for too long can make them worse.

Do not take Codipar Effervescent Tablets if:

  • you are allergic to paracetamol, codeine phosphate or any of the other ingredients of this medicine (listed in section 6)
  • you suffer from breathing problems, for example chronic bronchitis or emphysema or are suffering an asthma attack
  • you are taking monoamine oxidase inhibitors (MAOIs) or have been taking them within the last two weeks MAOIs, such as phenelzine, moclobemide or isocarboxazid, are medicines used to treat depression
  • you have just had a head injury or suffer from increased pressure on the brain
  • you have severe problems with your kidneys or liver
  • you know that you metabolise very rapidly codeine into morphine
  • you are breast feeding
  • you drink a lot of alcohol
  • you have recently had an operation to your gall bladder.

Codipar Effervescent Tablets should not be taken by children under 12 years of age.

Warnings and precautions

Talk to your doctor or pharmacist or nurse before taking Codipar Effervescent Tablets if:

  • you have any stomach pains or other sudden problems in your abdomen (belly)
  • you are elderly
  • you have liver or kidney problems, because the dose might need to be lower
  • your prostate is larger than normal or you have a narrowing of your urethra (tube through which urine is passed)
  • you feel you have taken Codipar Effervescent Tablets for a long time. You may develop a dependence on Codipar Effervescent Tablets which may be harmful.
  • you are taking any medicine from the group of medicines known as benzodiazepines. Taking these medicines with Codipar Effervescent Tablets may result in sedation, difficulties in breathing (respiratory depression), coma and may be fatal. Even if benzodiazepines are prescribed, your doctor may need to change the dose, the duration of treatment or monitor you regularly.

Codeine is transformed to morphine in the liver by an enzyme. Morphine is the substance that produces pain relief. Some people have a variation of this enzyme and this can affect people in different ways. In some people, morphine is not produced or produced in very small quantities, and it will not provide enough pain relief. Other people are more likely to get serious side effects because a very high amount of morphine is produced. If you notice any of the following side effects, you must stop taking this medicine and seek immediate medical advice: slow or shallow breathing, confusion, sleepiness, small pupils, feeling or being sick, constipation, lack of appetite.

Children and adolescents

Use in children and adolescents after surgery

Codeine must not be used for pain relief in children and adolescents after removal of their tonsils or adenoids due to Obstructive Sleep Apnoea Syndrome (sleep disruption due to respiratory pauses).

Use in children with breathing problems

Codeine is not recommended in children with breathing problems, since the symptoms of morphine toxicity may be worse in these children.

Other medicines and Codipar Effervescent Tablets

Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. Some medicines interact with each other and this can alter their effect. It is particularly important to tell your doctor or pharmacist if you are taking the following medicines:

  • medicines to treat depression such as amitriptyline, fluoxetine, sertraline etc
  • medicines used to treat high blood pressure such as furosemide, amiloride or bendroflumethiazide
  • MAOIs used to treat depression, taken within the last 14 days (refer to “do not take if” in section 2 above)
  • medicines to treat mental illness, e.g. chlorpromazine, haloperidol etc
  • sedatives and sleeping tablets, e.g. temazepam and diazepam
  • medicines for irregular heart beats (mexiletine, quinine or quinidine)
  • drugs used to dry fluids in the mouth and lungs known as anticholinergics
  • medicines to treat diarrhoea or sickness (metoclopramide, domperidone)
  • medicines to treat epilepsy (e.g. phenytoin and carbamazepine)
  • colestyramine, used to treat high levels of lipids in your blood, or for problems related to your bile duct
  • ritonavir, used to treat HIV
  • other strong painkillers called opioids
  • medicines which prevent blood clotting (anticoagulants such as warfarin).
  • Concomitant use of Codipar Effervescent Tablets and sedative medicines such as benzodiazepines or related drugs increases the risk of drowsiness, difficulties in breathing (respiratory depression), coma and may be life-threatening. Because of this, concomitant use should only be considered when other treatment options are not possible.

However if your doctor does prescribe Codipar Effervescent Tablets together with sedative medicines the dose and duration of concomitant treatment should be limited by your doctor.

Please tell your doctor about all sedative medicines you are taking, and follow your doctor’s dose recommendation closely. It could be helpful to inform friends or relatives to be aware of the signs and symptoms stated above. Contact your doctor when experiencing such symptoms.

Some products which can be bought without a prescription may contain paracetamol or codeine, so always check the labels for ingredients.

Codipar Effervescent Tablets with food, drink and alcohol

Do not drink alcohol whilst taking Codipar Effervescent Tablets.

Pregnancy, fertility and breast-feeding

If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Codipar Effervescent Tablets should not be used during pregnancy as they can affect the baby and can cause breathing problems when the baby is born. Do not take codeine while you are breast feeding. Codeine and morphine passes into breast milk. There is no data on the effects of this medicine on human fertility.

Driving and using machines

Codipar Effervescent Tablets may cause dizziness or drowsiness and you should not drive or operate machinery if you are affected this way. Codeine may disturb your vision.

This medicine can affect your ability to drive. Do not drive whilst taking this medicine until you know how this medicine affects you. It may be an offence to drive if your ability to drive safely is affected.

There is further information for patients who are intending to drive in Great Britain - go to https://www.gov.uk/drug-driving-law

Important information about some of the ingredients of Codipar Effervescent Tablets

This medicine contains sorbitol (389mg per tablet), which is a sugar. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.

This medicine contains 379 mg sodium in each tablet. This should be taken into consideration by patients on a controlled sodium (salt) diet.

3. HOW TO TAKE CODIPAR EFFERVESCENT TABLETS

Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.

Method of administration

The tablets must be put in a glass of water and allowed to completely dissolve. Drink the resulting solution immediately. Do not chew or bite your tablets.

Dose:

Adults:

The usual dosage is two tablets every six hours as needed. You should not take more than 8 tablets in 24 hours. If you feel the effect of Codipar Effervescent Tablets is too strong or too weak, speak to your doctor or pharmacist. This medicine should not be taken for more than 3 days. If the pain does not improve after 3 days, talk to your doctor for advice.

Older people:

A lower dosage may be needed if you are elderly or have other medical problems. Check with your doctor about this.

Use in children and adolescents

The recommended dose for children aged 16 and over is two tablets taken every six hours. You should not take more than eight tablets in any 24-hour period.

The recommended dose for children aged 12 to 15 years is one tablet taken every six hours, up to a maximum of four tablets in any 24-hour period.

Codipar Effervescent Tablets are not recommended for children under 12 years. Do not take with any other paracetamol-containing products. Do not exceed the stated dose.

If you take more Codipar Effervescent Tablets than you should

Talk to a doctor at once if you take too much of this medicine even if you feel well. This is because too much paracetamol can cause delayed, serious liver damage. Bring the remaining tablets and this leaflet with you so that the medical staff know what you have taken.

If you forget to take Codipar Effervescent Tablets

Do not take a double dose to make up for a forgotten dose. If you forget to take a dose then take your next dose at the usual time.

If you stop taking Codipar Effervescent Tablets

Codipar Effervescent Tablets can become habit forming. This is called dependence (addiction). If you stop taking your medicine suddenly it can cause withdrawal symptoms such as restlessness and irritability. Your doctor will stop your tablets gradually to avoid you having these withdrawal symptoms. If you find you need to use this product all the time, it is important to consult your doctor. If you have any further questions on the use of this medicine, ask your doctor or pharmacist or nurse.

4. POSSIBLE SIDE EFFECTS

Like all medicines, this medicine can cause side effects, although not everybody gets them.

The following side effects may happen with this medicine:

Some side effects can be serious and you should tell your doctor immediately if you notice the following

  • any sudden wheeziness, difficulty in breathing, swelling of eyelids, face or lips, rash or itching (especially affecting your whole body), sharp drop in blood pressure, nettle rash (urticaria) should be reported to a doctor. This could be because of anaphylactic shock or anaphylactic reaction
  • changes in blood cells, such as low number of cells which fight infection and of cells which are involved in blood clotting. Bruising more easily, sore throat or other signs of infection. This could be because of blood problem (such Blood dyscrasias including thrombocytopenia and agranulocytosis)
  • severe stomach pain, which may reach through to your back. This could be a sign of inflammation of the pancreas (pancreatitis)
  • very rare cases of serious skin reaction have been reported.

Tell your doctor or pharmacist if any of the following side effects gets serious or lasts longer than a few days:

The following side effects have also been reported:

Common (may affect up to 1 in 10 people)

  • a feeling of extra well being, or of disorientation
  • light-headedness, dizziness, sleepiness, headache
  • slow or weak breathing
  • feeling sick (nausea), vomiting, constipation, stomach pain
  • itching (pruritus), rash, hives in small areas of the skin (urticaria).

Rare (may affect up to 1 in 1,000 people)

  • allergic reaction which could include hives, itching, rashes, watery, red eyes.

Not known (frequency cannot be estimated from the available data)

  • hives affecting deeper skin layers (angioedema)
  • taking codeine regularly for a long time can lead to addiction, which might cause you to feel restless and irritable when you stop taking this medicine
  • confusion, drowsiness
  • small eye pupils
  • difficulty in breathing
  • liver damage, especially in heavy drinkers
  • difficulty in passing urine, inability to empty the bladder.

If any of the side effects become serious, or if you notice any side effect not listed in this leaflet, please tell your doctor or pharmacist.

Reporting of side effects:

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly (see details below)

United Kingdom

The Yellow Card Scheme
Website: www.mhra.gov.uk/yellowcard

or search for MHRA Yellow Card in the Google Play or Apple App Store or

Ireland

HPRA Pharmacovigilance
Earlsfort Terrace
IRL - Dublin 2
Tel: +353 1 6764971
Fax: +353 1 6762517
Website: www.hpra.ie

By reporting side effects you can help provide more information on the safety of this medicine.

5. HOW TO STORE CODIPAR EFFERVESCENT TABLETS

  • Keep this medicine out of the sight and reach of children.
  • Do not use Codipar Effervescent Tablets after the expiry date which is stated on the carton and the blister. The expiry date refers to the last day of that month.
  • Do not store above 25°C.

Medicines should not be disposed of via wastewater. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.

6. CONTENTS OF THE PACK AND OTHER INFORMATION

What Codipar Effervescent Tablets contain

  • The active substances are codeine phosphate hemihydrate, 15mg and paracetamol, 500mg
  • The other ingredients are sodium hydrogen carbonate, sodium carbonate anhydrous, citric acid anhydrous, sorbitol neosorb P60 W, povidone K30, sodium saccharin, macrogol 6000 and grapefruit flavour.

What Codipar Effervescent Tablets look like and contents of the pack

Codipar Effervescent tablets are white circular tablets,

Codipar Effervescent tablets are available in aluminium: polyethylene foils strips packs of 100 effervescent tablets (25 strips of 4 tablets).

Marketing Authorisation Holder:

Mercury Pharmaceuticals Ltd
Capital House
85 King William Street
London
EC4N 7BL
UK

Manufactured By:

Unither Industries
ZI du Malcourlet
03800 Gannat
France

This leaflet was last revised in: November 2018

Codipar is the registered trademark of Mercury Pharma Group Ltd.